HONG KONG – Celltrion Inc., of Incheon, South Korea, recently received marketing approval from the European Commission for its biosimilar trastuzumab, Herzuma. Based on Roche Holding AG and Genentech Inc.'s targeted therapy, Herceptin, Herzuma is cleared for marketing in the 28 member states of the European Union (EU), in addition to Norway, Liechtenstein and Iceland. Read More

PERTH, Australia – Australian stem cell therapy company Mesoblast Ltd. said its allogeneic mesenchymal stem cell candidate, MSC-100-IV (remestemcel-L), met the primary endpoint in a phase III trial in children with refractory acute graft-vs.-host disease (aGVHD). Read More

HONG KONG – Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases. Read More

HONG KONG – Biotech companies that have not yet generated any revenue can seek listing on the Main Board of the Hong Kong Stock Exchange (HKEX). The exchange proposed the new policy Friday as part of the effort to lure more firms to go public, bolstering Hong Kong's biotech development. Read More

HONG KONG – Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger. Read More

Taiwan Liposome Co. Ltd., of Taipei, Taiwan, which is focused on developing nanomedicines for pain management, ophthalmology and oncology, said it filed a registration statement on form F-1 with the SEC for a proposed U.S. IPO of its American depositary shares (ADSs) representing shares of common stock. The company has applied to list its ADSs on Nasdaq under the trading symbol TLC. Read More

Canbridge Life Sciences Ltd., of Beijing, appointed Michael Glynn to its advisory team, where he will provide leadership, direction and input on the company's commercial strategy and planning as it prepares for its first commercial launch.  Read More